Literature DB >> 11880413

Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.

François Coutlée1, Patti Gravitt, Janet Kornegay, Catherine Hankins, Harriet Richardson, Normand Lapointe, Hélène Voyer, Eduardo Franco.   

Abstract

The novel PGMY L1 consensus primer pair is more sensitive than the MY09 and MY11 primer mix for detection and typing with PCR of human papillomavirus (HPV) DNA in genital specimens. We assessed the diagnostic yield of PGMY primers for the detection and typing of HPV by comparing the results obtained with PGMY09/PGMY11 and MY09/MY11/HMB01 on 299 genital samples. Amplicons generated with PGMY primers were typed with the line blot assay (PGMY-line blot), while HPV amplicons obtained with the degenerate primer pool MY09/MY11/HMB01 were detected with type-specific radiolabeled probes in a dot blot assay (standard consensus PCR test). Cervicovaginal lavage samples (N = 272) and cervical scrape samples (N = 27) were tested in parallel with both PCR tests. The PGMY-line blot test detected the presence of HPV DNA more frequently than the standard consensus PCR assay. The concordance for HPV typing between the two assays was 84.3% (214 of 255 samples), for a good kappa value of 0.69. Of the 177 samples containing HPV DNA by at least one method, 40 samples contained at least one HPV type detected only with PGMY-line blot, whereas positivity exclusively with the standard consensus PCR test was found for only 7 samples (P < 0.001). HPV types 45 and 52 were especially more frequently detected with PGMY than MY primers. However, most HPV types were better amplified with PGMY primers, including HPV-16. Samples with discordant results between the two PCR assays more frequently contained multiple HPV types. Studies using PGMY instead of MY primers have the potential to report higher detection rates of HPV infection not only for newer HPV types but also for well-known genital types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880413      PMCID: PMC120235          DOI: 10.1128/JCM.40.3.902-907.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer.

Authors:  E Guerrero; R W Daniel; F X Bosch; X Castellsagué; N Muñoz; M Gili; P Viladiu; C Navarro; M L Zubiri; N Ascunce
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

3.  The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection.

Authors:  E L Franco
Journal:  Epidemiology       Date:  1991-03       Impact factor: 4.822

Review 4.  Human pathogenic papillomavirus types: an update.

Authors:  E M de Villiers
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

5.  Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis.

Authors:  M H Mayrand; F Coutlée; C Hankins; N Lapointe; P Forest; M de Ladurantaye; M Roger
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  Incidence of cervical squamous intraepithelial lesions in HIV-infected women.

Authors:  T V Ellerbrock; M A Chiasson; T J Bush; X W Sun; D Sawo; K Brudney; T C Wright
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

7.  Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.

Authors:  D G Harnish; L M Belland; E E Scheid; T E Rohan
Journal:  Mol Cell Probes       Date:  1999-02       Impact factor: 2.365

8.  Genital human papillomavirus infection in female university students as determined by a PCR-based method.

Authors:  H M Bauer; Y Ting; C E Greer; J C Chambers; C J Tashiro; J Chimera; A Reingold; M M Manos
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

9.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

10.  Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results.

Authors:  R A Tucker; P R Johnson; W C Reeves; J P Icenogle
Journal:  J Virol Methods       Date:  1993-08       Impact factor: 2.014

View more
  52 in total

1.  Human papillomavirus detection in genital samples by novel PGMY Primers.

Authors:  Mahima Lall
Journal:  Med J Armed Forces India       Date:  2015-07-02

2.  Comparison of the immune microenvironment of the oral cavity and cervix in healthy women.

Authors:  Carole Fakhry; Morgan A Marks; Robert H Gilman; Lilia Cabrerra; Pablo Yori; Margaret Kosek; Patti E Gravitt
Journal:  Cytokine       Date:  2013-09-07       Impact factor: 3.861

3.  Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Authors:  François Coutlée; Danielle Rouleau; Patrick Petignat; Georges Ghattas; Janet R Kornegay; Peter Schlag; Sean Boyle; Catherine Hankins; Sylvie Vézina; Pierre Coté; John Macleod; Hélène Voyer; Pierre Forest; Sharon Walmsley; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types.

Authors:  Tarik Gheit; Stefano Landi; Federica Gemignani; Peter J F Snijders; Salvatore Vaccarella; Silvia Franceschi; Federico Canzian; Massimo Tommasino
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

5.  Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens.

Authors:  Véronique Fontaine; Corinne Mascaux; Christine Weyn; Aurore Bernis; Nathalie Celio; Philippe Lefèvre; Leonard Kaufman; Christian Garbar
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

6.  Evaluation of different techniques for identification of human papillomavirus types of low prevalence.

Authors:  Ivan Sabol; Martina Salakova; Jana Smahelova; Michal Pawlita; Markus Schmitt; Nina Milutin Gasperov; Magdalena Grce; Ruth Tachezy
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

7.  Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women.

Authors:  Morgan A Marks; Raphael P Viscidi; Kathryn Chang; Michelle Silver; Anne Burke; Roslyn Howard; Patti E Gravitt
Journal:  Cytokine       Date:  2011-10-19       Impact factor: 3.861

8.  Epidemiology of head and neck squamous cell cancer among HIV-infected patients.

Authors:  Gypsyamber Dʼsouza; Thomas E Carey; William N William; Minh Ly Nguyen; Eric C Ko; James Riddell; Sara I Pai; Vishal Gupta; Heather M Walline; J Jack Lee; Gregory T Wolf; Dong M Shin; Jennifer R Grandis; Robert L Ferris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

9.  Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.

Authors:  Matthew H Stenmark; Jonathan B McHugh; Matthew Schipper; Heather M Walline; Christine Komarck; Felix Y Feng; Francis P Worden; Gregory T Wolf; Douglas B Chepeha; Mark E Prince; Carol R Bradford; Suresh K Mukherji; Avraham Eisbruch; Thomas E Carey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-01       Impact factor: 7.038

10.  Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.

Authors:  Yuri Agrawal; Wayne M Koch; Weihong Xiao; William H Westra; Anna L Trivett; David E Symer; Maura L Gillison
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.